|Title:||Effect of Plasmapheresis for Acute Humoral Rejection After Heart Transplantation||Authors:||SHOEI-SHEN WANG
|Issue Date:||2006||Journal Volume:||38||Journal Issue:||10||Start page/Pages:||3692-3694||Source:||Transplantation Proceedings||Abstract:||
Objective: The objective of this study was to report our experience of treating acute humoral rejection with plasmapheresis in heart transplant (HT) recipients. Patients and Methods: From May 1996 to December 2005, 238 HTs were performed using therapy with cyclosporine or tacrolimus, azathioprine or mycophenolate mofetil, and prednisolone as well as induction treatment with rabbit anti-human thymocyte globulin. Endomyocardial biopsy for rejection surveillance was performed weekly for the first month, monthly for 3 months, yearly after the first year, and whenever rejection was suspected. Immunofluorescence studies with IgG, IgM, C3, C4, C1q, and HLA-DR were performed routinely on the first month biopsy. After a 2-year trial, immunofluorescence studies were not performed routinely, because no significant findings were observed; thus they were performed only when clinical deterioration, unstable hemodynamic status, or suspicion of rejection occurred on routine echocardiographic examinations. Plasmapheresis with fresh frozen plasma exchanging twice the blood volume of the patients was performed for 5 days. Rescue immunosuppression with methylprednisolone (1 g/d) was delivered for 3 days and the immunosuppressants changed, but no intravenous immunoglobulin was prescribed. Results: Twelve patients suffered biopsy-proven acute humoral rejection at 3 days to 32 months after HT (mean, 9.4 months). Immunofluorescence studies showed positive HLA-DR in 7 patients; IgG in 4 patients; IgM in 1 patient; C3 in 4 patients; C4 in 1 patient; and C1q in 1 patient. One patient who was 3 months after HT showed only C1q positive but was treated with extracorporeal membrane oxygenation and intra-aortic balloon pumping support and died 1-month after plasmapheresis. Another patient who deteriorated on the 3rd postoperative day and died 3 days after plasmapheresis was considered to have vascular rejection by interstitial edema, vacuolated endothelial cells and no pathognomonic clinical features, although there was no positive immunofluorescence result. All other subjects were discharged from the hospital, although 3 required mechanical support during plasmapheresis. Hypotension with hypocalcemia was frequently noted during plasmapheresis. The 1-year survival rate was 75% ± 11%, and 5-year survival rate, 51% ± 15%. Conclusion: Plasmapheresis with concurrent rescue immunosuppression was an effective treatment for acute humoral rejection in HT even with unstable hemodynamics. ? 2006 Elsevier Inc. All rights reserved.
|ISSN:||0041-1345||DOI:||10.1016/j.transproceed.2006.10.060||metadata.dc.subject.other:||azathioprine; cyclosporin; fresh frozen plasma; HLA DR antigen; immunoglobulin; immunoglobulin antibody; immunoglobulin G; immunoglobulin M; immunosuppressive agent; methylprednisolone; mycophenolic acid 2 morpholinoethyl ester; prednisolone; tacrolimus; thymocyte antibody; acute graft rejection; acute humoral rejection; adult; aorta balloon; article; clinical article; clinical feature; controlled study; endothelium cell; exchange blood transfusion; extracorporeal oxygenation; female; graft recipient; heart graft; heart muscle biopsy; heart transplantation; hemodynamics; human; human tissue; humoral immunity; hypocalcemia; hypotension; immunofluorescence; immunosuppressive treatment; male; plasmapheresis; postoperative period; priority journal; survival rate; time series analysis; ABO Blood-Group System; Acute Disease; Adult; Antibody Formation; Biopsy; Combined Modality Therapy; Female; Flow Cytometry; Graft Rejection; Heart Transplantation; Humans; Immunosuppressive Agents; Male; Middle Aged; Plasmapheresis; Retrospective Studies
|Appears in Collections:||醫學系|
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.